Read + Share
Konstantinopoulos PA, Lee JM, Gao B, Miller R, et al. A Phase 2 study of prexasertib (LY2606368) in platinum resistant or refractory
recurrent ovarian cancer. Gynecol Oncol 2022 Sep 30. pii: S0090-8258(22)01839.
PMID: 36192237
|
 |
|
Konstantinopoulos PA, Lee JM, Gao B, Miller R, et al. A Phase 2 study of prexasertib (LY2606368) in platinum resistant or refractory
recurrent ovarian cancer. Gynecol Oncol 2022 Sep 30. pii: S0090-8258(22)01839.
PMID: 36192237
|
|
|
|